These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17683364)

  • 1. Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference.
    Klein HG; Anderson D; Bernardi MJ; Cable R; Carey W; Hoch JS; Robitaille N; Sivilotti ML; Smaill F
    Vox Sang; 2007 Aug; 93(2):179-82. PubMed ID: 17683364
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference.
    Klein HG; Anderson D; Bernardi MJ; Cable R; Carey W; Hoch JS; Robitaille N; Sivilotti ML; Smaill F
    Transfusion; 2007 Dec; 47(12):2338-47. PubMed ID: 18036075
    [No Abstract]   [Full Text] [Related]  

  • 3. The consensus development process in transfusion medicine: does it add value?
    Sher GD; Devine DV
    Transfusion; 2007 Dec; 47(12):2176-9. PubMed ID: 18036072
    [No Abstract]   [Full Text] [Related]  

  • 4. Properties of pathogen-inactivated plasma components.
    Prowse C
    Transfus Med Rev; 2009 Apr; 23(2):124-33. PubMed ID: 19304113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening.
    McDonald CP
    Transfus Med; 2006 Dec; 16(6):381-96. PubMed ID: 17163869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop.
    Klein HG; Glynn SA; Ness PM; Blajchman MA;
    Transfusion; 2009 Jun; 49(6):1262-8. PubMed ID: 19392769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Salmonella reduction in Danish abattoirs.
    Lawson LG; Jensen JD; Christiansen P; Lund M
    Int J Food Microbiol; 2009 Aug; 134(1-2):126-32. PubMed ID: 19427047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDC launches surveillance system to improve blood transfusion safety.
    Kuehn BM
    JAMA; 2010 Apr; 303(15):1467. PubMed ID: 20407049
    [No Abstract]   [Full Text] [Related]  

  • 9. How to evaluate whether a new technology in the operating room is cost-effective from society's viewpoint.
    Tan JM; Macario A
    Anesthesiol Clin; 2008 Dec; 26(4):745-64, viii. PubMed ID: 19041627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment and cost-effectiveness/utility analysis.
    Busch M; Walderhaug M; Custer B; Allain JP; Reddy R; McDonough B
    Biologicals; 2009 Apr; 37(2):78-87. PubMed ID: 19243972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations for rationally-based hemotherapy].
    Welte M; Hachenberg T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):184-5. PubMed ID: 19266419
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical technologies can carry big payoff, big costs. How to assess needs and build strategies.
    Carpenter D
    Trustee; 2008; 61(7):8-12, 14, 19 passim. PubMed ID: 18773556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic evaluation of health technologies: theory and practice].
    Abadi-Korek I; Shemer J
    Harefuah; 2008 Jun; 147(6):509-11, 574. PubMed ID: 18693627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How I minimize mistransfusion risk in my hospital.
    Aubuchon JP
    Transfusion; 2006 Jul; 46(7):1085-9. PubMed ID: 16836553
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation.
    Lefrère JJ; Laperche S; Roudot-Thoraval F
    Vox Sang; 2008 Jul; 95(1):76-8. PubMed ID: 18393946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for ensuring the safety of blood transfusion].
    Hara H
    Rinsho Ketsueki; 2004 Jun; 45(6):443-5. PubMed ID: 15287518
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleeding and transfusion in acute coronary syndromes: a shift in the paradigm.
    Bassand JP
    Heart; 2008 May; 94(5):661-6. PubMed ID: 18411361
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood matters. Interview by Steven Harulow.
    Ryan M
    Aust Nurs J; 2003 Jun; 10(11):21. PubMed ID: 18567386
    [No Abstract]   [Full Text] [Related]  

  • 20. Current opinions on the role of pathogen reduction technology in improving the viral safety of blood and derivatives.
    Seghatchian J
    Transfus Apher Sci; 2008 Aug; 39(1):49-50. PubMed ID: 18617442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.